IZOPEVA Trademark

Trademark Overview

On Thursday, July 21, 2016, a trademark application was filed for IZOPEVA with the United States Patent and Trademark Office. The USPTO has given the IZOPEVA trademark a serial number of 87112094. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 17, 2020. This trademark is owned by Bristol-Myers Squibb Company. The IZOPEVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
izopeva

General Information

Serial Number87112094
Word MarkIZOPEVA
Filing DateThursday, July 21, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 17, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 27, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, August 17, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 17, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, January 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 2, 2020EXTENSION 5 GRANTED
Friday, December 20, 2019EXTENSION 5 FILED
Thursday, January 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 20, 2019TEAS EXTENSION RECEIVED
Saturday, June 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2019EXTENSION 4 GRANTED
Thursday, June 20, 2019EXTENSION 4 FILED
Thursday, June 20, 2019TEAS EXTENSION RECEIVED
Wednesday, December 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 24, 2018EXTENSION 3 GRANTED
Monday, December 24, 2018EXTENSION 3 FILED
Monday, December 24, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 10, 2018EXTENSION 2 GRANTED
Tuesday, July 10, 2018EXTENSION 2 FILED
Tuesday, July 10, 2018TEAS EXTENSION RECEIVED
Friday, January 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 10, 2018EXTENSION 1 GRANTED
Wednesday, January 10, 2018EXTENSION 1 FILED
Wednesday, January 10, 2018TEAS EXTENSION RECEIVED
Tuesday, July 11, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 16, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 2, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, November 2, 2016PRIORITY ACTION E-MAILED
Wednesday, November 2, 2016PRIORITY ACTION WRITTEN
Tuesday, November 1, 2016ASSIGNED TO EXAMINER
Wednesday, July 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 25, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

izopeva diseases pharmaceutical human anti preparations disorders organ solid auto immune